HUSSMAN STRATEGIC ADVISORS, INC.
Position in CORT — Corcept Therapeutics Inc
CIK 1179475
ELLICOTT CITY, MD
Position in CORT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5,079,060
+$3,982,860 QoQ
Shares Held
126,000
+300.0% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HUSSMAN STRATEGIC ADVISORS, INC. holds $50,152,977 across 23 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
42,000 | $4,761,120 | |
| 2 | AUPH |
Aurinia Pharmaceuticals Inc.
|
210,000 | $3,563,700 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
42,000 | $3,287,340 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,250 | $3,273,585 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
31,500 | $2,984,625 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
52,500 | $2,884,350 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
147,000 | $2,641,590 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
31,500 | $2,569,455 |
All Filings in CORT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,079,060 | 126,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,096,200 | 31,500 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,617,965 | 31,500 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,082,800 | 42,000 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,797,240 | 42,000 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,116,380 | 42,000 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,943,760 | 42,000 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,411,450 | 105,000 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,115,960 | 84,000 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,705,200 | 52,500 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,716,750 | 63,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,082,600 | 93,600 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,417,256 | 111,600 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,888,830 | 93,000 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,179,360 | 124,000 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $3,317,310 | 139,500 | Shares | Sole | 2022-09-12 | |
| 2022-03-31 | $1,171,040 | 52,000 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,029,600 | 52,000 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,050,400 | 155,000 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,046,000 | 93,000 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,712,880 | 72,000 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $3,753,960 | 143,500 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $4,439,550 | 255,000 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $3,027,600 | 180,000 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,831,060 | 154,000 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||